Article
Merck's First-Quarter Earnings Beat Estimates. The Stock Is Rising.
Rating:
0.0
Views:
44
Likes:
1
Library:
1
The big pharma company has been getting ready for the loss of patent protection for the cancer immunotherapy Keytruda in 2028. Merck also raised guidance.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value